Press Release

AUSTIN, TX / ACCESS Newswire / August 13, 2025 / Aspira Women’s Health Inc. (“Aspira”) (OTCQB:AWHL), an AI enhanced bio-analytics based women’s health company focused on delivering leading noninvasive gynecologic disease diagnostic and disease management tools, announced today its results of operations for the three and six months ended June 30, 2025. The Company also reported early progress…

AUSTIN, TX / ACCESS Newswire / July 15, 2025 / Aspira Women’s Health Inc. (“Aspira” or the “Company”) (QTCQB:AWHL), an AI enhanced bio-analytical based women’s health company focused on delivering the leading tools critical to gynecologic disease diagnostics and disease management, today announced the appointment of Jane Pine Wood to the Board of Directors, effective July 11, 2025.…

Aspira and Dorsata Launch Clinical Workflow Tool for Adnexal Masses, Now Live for All Dorsata Clients, Adnexal Mass Evidence-Based Decision Support AUSTIN, TX AND WASHINGTON, DC / ACCESS Newswire / June 17, 2025 / Aspira Women’s Health Inc. a bio-analytical-based women’s health company focused on gynecologic disease diagnostics, and Dorsata, a leading clinical decision-support and provider workflow platform…

AUSTIN, TX AND WASHINGTON, DC / ACCESS Newswire / June 11, 2025 / Aspira Women’s Health Inc., (“Aspira”) (OTCQB:AWHL), an AI enhanced bio-analytics based women’s health company focused on delivering leading noninvasive gynecologic disease diagnostic and disease management tools, announces an update from the Advanced Research Projects Agency for Health’s ( ARPA-H ) Sprint for Women’s Health program…

AUSTIN, TX / ACCESS Newswire / May 19, 2025 / Aspira Women’s Health Inc. (“Aspira”) (OTCQB:AWHL), an AI enhanced bio-analytics based women’s health company focused on delivering leading noninvasive gynecologic disease diagnostic and disease management tools, announced today its results of operations for the three-month period ended March 31, 2025. The Company also reported early progress under its…

AUSTIN, TX / ACCESS Newswire / May 7, 2025 / Aspira Women’s Health Inc. (“Aspira”) (OTCQB:AWHL), an AI enhanced bio-analytics based women’s health company focused on delivering the leading tools critical to gynecologic disease diagnostics and disease management, today announced it has successfully completed the process of transitioning to the OTCQB markets exchange. The Company begins trading on…

Aspira Women’s Health Submits the Third Milestone of ARPA-H $10 Million Award AUSTIN, TX / ACCESS Newswire / May 1, 2025 / Aspira Women’s Health Inc. (“Aspira”) (OTC PINK:AWHL), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced the successful submission of its third development milestone of its Advanced Research…

SHELTON, CT / ACCESS Newswire / April 17, 2025 / Aspira Women’s Health Inc. (“Aspira” or the “Company”) (NASDAQ:AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that at beginning of trading on April 17, 2025, the Company expects that its Common Stock will begin trading under its new…

SHELTON, CT / ACCESS Newswire / April 16, 2025 / Aspira Women’s Health Inc. (“Aspira” or the “Company”) (NASDAQ:AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced that on April 15, 2025, the Company received written notice (the “Notice”) from the Office of General Counsel of The Nasdaq Stock…

New Directors Bring Extensive Commercial Healthcare Relationships to Expand Business Development Opportunities. AUSTIN, TX / ACCESS Newswire / April 8, 2025 / Aspira Women’s Health Inc. (“Aspira” or the “Company”) (NASDAQ:AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced the appointment of three new Directors to its Board of…